PGR:NYSE

Progressive Corporation (The)

Data as of 2026-03-09 - not real-time

$206.80

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Progressive Corp (PGR) trades at $206.8, well below its DCF fair value of $472, delivering a compelling valuation gap. The stock sits just above the 20‑day SMA ($207.27) but remains under the 50‑day ($209.57) and 200‑day ($234.57) averages, signaling a short‑term bearish bias. Technical momentum is mixed – the MACD histogram is positive and the signal line is bullish, yet RSI at 46.8 points to neutral pressure and volume is on a downtrend. Fundamentally, PGR posts 12.2% revenue growth, a robust ROE of 40.4%, and generates $11.8 B of free cash flow, supporting its 6.6% dividend yield and a 72% payout ratio. The balance sheet is strong with $10.1 B cash offsetting $7.1 B debt, yielding a low net‑debt profile and a beta of 0.28, indicating limited market volatility exposure. However, a 30‑day volatility of 24.4% and a max drawdown near 31% highlight price swing risks.
Overall, the combination of deep undervaluation, solid cash generation, and a defensive risk profile makes PGR an attractive buy for medium to long horizons, while short‑term positioning should remain cautious amid the bearish trend and waning volume.

Trading Recommendations

Short Term

< 1 year
hold
Conviction: 6/10

Key Factors

  • price hovering just above the $198.8 support level
  • bearish trend indicated by price below SMA200
  • decreasing volume suggesting weakening short‑term momentum

Medium Term

1–3 years
buy
Conviction: 8/10

Key Factors

  • DCF fair value of $472 implies ~15% upside
  • high ROE (40%) and strong free cash flow support earnings sustainability
  • attractive 6.6% dividend yield with solid payout coverage

Long Term

> 3 years
buy
Conviction: 9/10

Key Factors

  • consistent 12% revenue growth and expanding policies in force
  • low beta (0.28) provides defensive characteristics in volatile markets
  • net‑cash position and disciplined capital management underpin long‑term stability

Key Metrics & Analysis

Financial Health

Revenue Growth12.20%
Profit Margin12.90%
P/E Ratio10.8
ROE40.45%
ROA7.92%
Debt/Equity23.42
P/B Ratio4.0
Op. Cash Flow$17.5B
Free Cash Flow$11.8B
Industry P/E17.4

Technical Analysis

TrendBearish
RSI46.8
Support$198.83
Resistance$214.97
MA 20$207.27
MA 50$209.57
MA 200$234.57
MACDBullish
VolumeDecreasing
Fear & Greed Index75.89

Valuation

Fair Value$472.20
Target Price$238.10
Upside/Downside15.14%
GradeUndervalued
TypeBlend
Dividend Yield6.60%

Risk Assessment

Beta0.28
Volatility24.45%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.